Rapid, High Tech Study of Ongoing Epidemic Creates New Paradigm for Outbreak Research
BALTIMORE, Md., July 27, 2011 /PRNewswire-USNewswire/ -- A team led by University of Maryland School of Medicine Institute for Genome Sciences researchers has unraveled the genomic code of the E.

Researchers at the University of Maryland School of Medicine have discovered a novel interaction between two proteins involved in regulating cell growth that could provide possible new drug targets for treating diffuse large B-cell lymphoma, the most common type of non-Hodgkin's lymphoma.

Community volunteers provide "safe haven" for testing over 4,500 Baltimoreans since 2009
BALTIMORE, June 28, 2011 /PRNewswire-USNewswire/ -- Project SHALEM has tested 3,556 Baltimoreans for HIV since 2009, and by the end of today, Project SHALEM hopes to increase this number by 1,000.

Experimental drug may help reprogram tumor cells to respond to hormone therapy
BALTIMORE, June 2, 2011 /PRNewswire-USNewswire/ -- A multicenter clinical trial led by a researcher at the University of Maryland Marlene and Stewart Greenebaum Cancer Center will evaluate a new approach to treat triple-negative breast cancer, an often-aggressive type of cancer that is more common among African-Americans and young women.

Doctors Investigate Long Illness and Death of Scientist Known as 'Father of Evolution'
BALTIMORE, May 6, 2011 /PRNewswire-USNewswire/ -- Now, 200 years after the birth of Charles Darwin, the father of evolution, doctors are putting modern medicine to the test to unravel the mystery of the painful illness that plagued the scientist for much of his life.

A pivoted catch designed to fall into a notch on a ratchet wheel so as to allow movement in only one direction (e.g. on a windlass or in a clock mechanism), or alternatively to move the wheel in one direction.